“…To construct photoresponsive polymer nanomedicines, researchers often incorporate light-responsive compounds, such as azobenzene [11], o-nitrobenzyl ester [11][12][13], coumarin [14,15], and spiroxamine derivatives [16], into the molecular structure of polymer chains. However, their responsive wavelengths are generally in the ultraviolet (UV) region, necessitating the use of UV light sources for drug release of the corresponding nanomedicines.…”